The Changes in the Endothelial Function and Haemostatic and Inflammatory Parameters in Subclinical and Overt Hyperthyroidism

• Published in: International Journal of Endocrinology Vol. 2013; no. 2013; pp. 964 - 970-217
• Main Authors: Popławska-Kita, Anna, Siewko, Katarzyna, Telejko, Beata, Modzelewska, Anna, Myśliwiec, Janusz, Milewski, Robert, Górska, Maria, Szelachowska, Małgorzata
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Limiteds 01-01-2013; Hindawi Puplishing Corporation; Hindawi Publishing Corporation; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Analysis; Antibodies; Blood pressure; Cell adhesion & migration; Endocrinology; Endothelium; Enzymes; Health risk assessment; Hormones; Hyperthyroidism; Immunoassay; Inflammation; Physiological aspects; Statistical analysis; Thyroid gland; United States > US
• ISSN: 1687-8337; 1687-8345
• DOI: 10.1155/2013/981638

Introduction. The aim of the present study was to compare the levels of circulating markers of endothelial function and low-grade inflammation in patients with subclinical and overt hyperthyroidism (OH) due to Graves disease (GD) and toxic nodular goiter (TNG). Material and Methods. The group studied consisted of 42 patients with GD, 75 patients with TNG, and 39 healthy controls. Results. Circulating markers of endothelial dysfunction were elevated in the patients with both SH and OH, but the concentrations of interleukin-12 (IL-12) (P<0.05), IL-18 (P<0.05), fibrinogen (P<0.01), and von Willebrand factor (vWF) (P<0.05) were significantly higher in the OH than in the SH group. The highest levels of IL-6, IL-12, IL-18, vWF, sVCAM-1, and fibrinogen were found in the patients with GD, but the differences between the GD, and TNG groups were not significant. In the subjects with OH serum IL-6 was positively associated with FT3 (R=0.276, P<0.05), FT4 (R=0.273, P<0.05), and thyroid peroxidase antibodies (R=0.346, P<0.01) levels. Conclusion. Our results may suggest that both SH and OH may be associated with endothelial dysfunction, which is reflected by decreased fibrinolytic activity, hypercoagulability, and increased levels of IL-6, IL-12, and IL-18 and depends not only on the cause but also on the degree of hyperthyroidism.